Deciphera Receives European Commission Approval Of Romvimza (Vimseltinib)

Refinitiv阅读少于1分钟

Ono Pharmaceutical Co Ltd 4528:

DECIPHERA RECEIVES EUROPEAN COMMISSION APPROVAL OF ROMVIMZA™ (VIMSELTINIB) FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

登录或创建永久免费帐户以阅读此新闻